Black Cohosh
Black cohosh (Actaea racemosa) is a perennial herb native to eastern North America that has been used traditionally by Native American populations and is now widely employed as a botanical supplement for the management of menopausal symptoms. Its bioactive constituents include triterpene glycosides and phenolic compounds.
Overview
Black cohosh (Actaea racemosa, formerly Cimicifuga racemosa) is a flowering plant in the Ranunculaceae (buttercup) family, native to the deciduous forests of eastern North America. It has a long history of use among Indigenous peoples for various gynecological and rheumatic conditions. In modern phytotherapy, black cohosh is primarily used for the alleviation of menopausal symptoms, including hot flashes, night sweats, mood disturbances, and sleep difficulties. Standardized extracts, particularly the isopropanolic extract (iCR), are among the most extensively studied herbal preparations for this indication.
The bioactive constituents of black cohosh include triterpene glycosides (such as actein and 23-epi-26-deoxyactein), phenolic acids (including caffeic acid, ferulic acid, and fukinolic acid), and other compounds. The mechanism of action remains incompletely understood and appears to be more complex than originally proposed. Early hypotheses suggesting direct estrogenic activity have not been consistently supported; instead, black cohosh may act through serotonergic pathways, modulation of dopaminergic activity, or as a selective estrogen receptor modulator (SERM) with tissue-specific effects.
Clinical trial results for black cohosh in menopausal symptom management have been mixed. Several trials and meta-analyses suggest modest efficacy in reducing the frequency and severity of hot flashes, while others report no significant benefit over placebo. The German Commission E and the American College of Obstetricians and Gynecologists have acknowledged its potential use. Rare cases of hepatotoxicity have been reported in postmarketing surveillance, although a direct causal relationship remains unestablished. Black cohosh should not be confused with blue cohosh (Caulophyllum thalictroides), which has a different safety profile and distinct pharmacological properties.
Mechanism of Action
Triterpene Glycoside Pharmacology
Black cohosh (Actaea racemosa, formerly Cimicifuga racemosa) contains characteristic cycloartane-type triterpene glycosides — principally actein, 23-epi-26-deoxyactein, and cimiracemoside A — alongside phenylpropanoid esters (caffeic and ferulic acid derivatives) and the guanidine alkaloid Nomega-methylserotonin. These triterpenes are the primary pharmacologically active constituents responsible for the extract's neuroendocrine effects (PMID: 12126456).
Serotonergic Activity & Thermoregulation
Black cohosh does not bind estrogen receptors (ERalpha/ERbeta) at physiologically relevant concentrations, despite historical classification as a phytoestrogen. Instead, its clinical effects on vasomotor symptoms (hot flashes) are mediated through serotonergic mechanisms. Nomega-methylserotonin and triterpene constituents bind 5-HT1A, 5-HT1D, and 5-HT7 receptors, modulating hypothalamic thermoregulatory centers. Activation of 5-HT1A receptors narrows the thermoneutral zone that widens during estrogen decline, reducing the frequency and severity of hot flashes (PMID: 19588529).
Dopaminergic & Mu-Opioid Receptor Binding
Actein and related triterpenes exhibit binding affinity for mu-opioid receptors and dopamine D2 receptors in hypothalamic and limbic regions. Mu-opioid agonism contributes to modulation of GnRH pulsatility, while D2 receptor activation may explain reported improvements in mood and sleep quality during menopause. This multi-receptor profile distinguishes black cohosh from single-target hormone therapies (PMID: 14586095).
Anti-Inflammatory & Bone-Protective Effects
Triterpene glycosides inhibit NF-kB activation and suppress osteoclastogenesis by reducing RANKL-induced signaling in bone marrow macrophages. Actein specifically downregulates NFATc1 expression (the master transcription factor for osteoclast differentiation), suggesting potential benefits in preventing menopause-associated bone loss (PMID: 20638425).
Reconstitution Calculator
Reconstitution Calculator
Calculate your peptide dosing
Set up a clean workspace with all supplies ready.
7x / week for weeks
Research
Reported Effects
Inconsistent Clinical Results:: Multiple reviews note that while some trials show benefits for menopausal symptoms, overall evidence quality is low and results are contradictory. Limited Modern Evidence:: Recent high-quality studies have failed to demonstrate clear efficacy, particularly in breast cancer survivors. Treatment Duration:: When effective, at least 4-12 weeks of continuous use may be required before therapeutic effects appear. Combination Therapy:: May show better results when combined with other supplements like soy isoflavones and lignans rather than as monotherapy
- Multiple reviews note that while some trials show benefits for menopausal symptoms, overall evidence quality is low and results are contradictory
- Recent high-quality studies have failed to demonstrate clear efficacy, particularly in breast cancer survivors
- When effective, at least 4-12 weeks of continuous use may be required before therapeutic effects appear
- May show better results when combined with other supplements like soy isoflavones and lignans rather than as monotherapy
Safety Profile
Common Side Effects
- Gastrointestinal disturbances are the most frequently reported side effects, including nausea, vomiting, stomach discomfort, and diarrhea
- Headache and dizziness are commonly reported, particularly during initial supplementation
- Weight gain and fluid retention have been observed in some users
- Vaginal spotting or breakthrough bleeding may occur due to estrogenic activity
Serious Adverse Effects
- Hepatotoxicity is the most significant safety concern; multiple case reports and regulatory reviews have linked black cohosh to liver injury ranging from elevated enzymes to acute liver failure requiring transplantation. Australia, the UK, and the EU require liver toxicity warnings on black cohosh products
- Rare reports of autoimmune hepatitis triggered by black cohosh supplementation
- Isolated cases of seizures have been reported, though causality has not been firmly established
- Rare cardiovascular events including bradycardia and hypotension have been documented
Contraindications
- Contraindicated in individuals with pre-existing liver disease, hepatitis, or elevated liver enzymes
- Should not be used by individuals with hormone-sensitive conditions (breast cancer, uterine cancer, endometriosis, uterine fibroids) due to estrogenic or estrogen-modulating activity, although the mechanism remains debated
- Not recommended for use exceeding 6 months due to insufficient long-term safety data
- Contraindicated in individuals with known allergy to plants in the Ranunculaceae (buttercup) family
Drug Interactions
- May interact with hepatotoxic drugs (statins, acetaminophen, methotrexate, ketoconazole) by compounding liver injury risk
- Potential interaction with hormone replacement therapy (HRT) and oral contraceptives due to estrogenic activity
- May potentiate the effects of antihypertensive medications, increasing risk of hypotension
- Theoretical interaction with CYP2D6 substrates (tamoxifen, codeine, certain antidepressants), as in vitro studies suggest inhibition of this enzyme
- May interact with anticoagulants, though clinical evidence is limited
Special Populations
- Contraindicated during pregnancy due to potential uterotonic effects; historically used to induce labor
- Not recommended during breastfeeding due to insufficient safety data
- Liver function should be monitored in all users; discontinue immediately if symptoms of liver injury appear (jaundice, dark urine, abdominal pain, unusual fatigue)
Pharmacokinetic Profile
Black Cohosh — Pharmacokinetic Curve
SubcutaneousQuick Start
- Typical Dose
- 40-80 mg per day of standardized extract (typically standardized to 27-deoxyactein)
Safety Profile
Common Side Effects
- Hepatotoxicity Risk:: Multiple case reports document liver damage ranging from mild elevation of liver enzymes to acute hepatitis, liver failure, and death
- Hematologic Effects:: Animal studies show dose-dependent anemia, macrocytosis, and potential vitamin B12 interference
- Common Mild Effects:: Dizziness, nausea, headache, rash, and vomiting reported with low frequency
- Allergic Reactions:: Rare but documented allergic reactions including skin sensitivity
References (8)
- [2]Review of black cohosh-induced toxicity and adverse clinical effects
→ Recent studies indicate Black Cohosh extract is not only ineffective for menopausal therapy but also induces genotoxicity through an aneugenic mode of action, with adverse effects ranging from mild reactions to acute liver damage and death.
- [3]Black Cohosh Herbal Extract and Hematologic Alterations in B6C3F1/N Mice
→ A National Toxicology Program study revealed Black Cohosh extract caused dose-dependent non-regenerative anemia with macrocytosis and micronuclei in mice, consistent with megaloblastic anemia due to functional cobalamin deficiency.
- [4]Is black cohosh estrogenic?
→ New data indicates Black Cohosh extracts do not bind to estrogen receptors, do not up-regulate estrogen-dependent genes, and do not stimulate growth of estrogen-dependent tumors in animal models, disputing the estrogenic theory.
- [5]Common Herbal Dietary Supplement-Drug Interactions
→ Black Cohosh is identified as having a low likelihood of drug interactions and can safely be taken with most medications with certain caveats, unlike supplements like St. John's wort and goldenseal.
- [6]Estimated Exposure to 6 Potentially Hepatotoxic Botanicals in US Adults
→ Black Cohosh was identified as one of the six most frequently reported hepatotoxic botanicals in the US, with increasing prevalence of use despite documented cases of liver toxicity.
- [7]The role of diet in managing menopausal symptoms: A narrative review
→ Review found that evidence for Black Cohosh efficacy in managing menopausal symptoms is inconsistent, and the overall quality of published clinical trials is low, requiring further high-quality research.
- [1]Assessing the combined effects of Black Cohosh, Soy Isoflavones, and SDG Lignans on menopausal symptoms: a randomized, double-blind, placebo-controlled clinical trial
→ A 90-day trial in postmenopausal women showed significant improvements in Menopause Rating Scale scores across all domains when Black Cohosh was combined with soy isoflavones and SDG lignans compared to placebo.
- [8]Black cohosh: an alternative therapy for menopause?
→ Review suggests Black Cohosh may be useful for hot flashes, sweating, insomnia, and anxiety, but a recent trial showed it was not effective for menopausal symptoms in breast cancer survivors taking tamoxifen, with at least 4-12 weeks of treatment required.
Bitter Melon Extract
Bitter Melon Extract, or Momordica charantia, is a medicinal plant compound containing bioactive substances like charantin and insulin-like peptides that mimic
BMP-2
BMP-2 is the most potent osteoinductive member of the bone morphogenetic protein family, capable of independently inducing the complete cascade of endochondral